Dragi colegi,
Vă așteptăm la Congresul Oncodigest, ediția a 10-a, ce se va desfășura online în perioada 12-13 noiembrie și 19-20 noiembrie 2021, fiind susținută de ESDO (ESDO Labelled Meeting).
Congresul este alcătuit din 2 simpozioane: Simpozionul Franco-Român de Oncologie Digestivă și Simpozionul Asociației pentru Studiul Tumorilor Neuroendocrine din România. Simpozionul Franco-Român se axează anul acesta pe tratamentul cancerului gastric și colorectal și este organizat în parteneriat cu FFCD (Fédération Francophone de Cancérologie Digestive).
Prezentările vor fi organizate într-o manieră interactivă, cu un program echilibrat care cuprinde atât prezentări ale ultimelor noutăți din oncologia digestivă, cât şi cazuri clinice şi discuţii.
Congresul se va bucura de o largă participare internațională, Simpozionul Franco-Român de Oncologie Digestivă având ca invitați renumiți profesori din Franța şi din România.
Sunt bineveniți toți cei interesați de oncologia digestivă, un domeniu de interfață între diferite specialități precum oncologia, gastroenterologia, chirurgia generală, imagistica medicală și anatomia patologică.
Cu prietenie,
Comitetul organizator
The Symposium of the Romanian Association for the Study of Neuroendocrine Tumors
Friday, 12th November 2021
14:50-15:00 Opening: Catalina Poiana, Mircea Manuc, Mircea Diculescu, Adina Croitoru
Session 1: Pancreatic NETs
Chair: Catalina Poiana, Mircea Manuc, Mircea Diculescu
15:00-15:20 An overview of pancreatic NETs (Cătălina Poiană)
15:20-15:40 Case report 1 (Catalina Poiana)
15:40-16:00 Case report 2 (Irina Sandra)
16:00-16:20 Discussion of clinical cases (Mircea Manuc)
16:20-16:40 Break
Session 2: Pancreatic NETs
Chair: Simona Fica, Simona Dima, Adina Croitoru
16:40-17:00 The role of surgery in pancreatic NETs (Simona Dima)
17:00-17:20 Case report 1 (Simona Fica)
17:20-17:40 Case report 2 (Tudor Stroie)
17:40-18:00 Discussion of clinical cases (Raluca Pătru)
18:00-18:30 IPSEN Symposium: Update on systemic therapy in pancreatic NETs (Marianne Pavel)
Educational Session organized by SROD with The Support of Servier Company
Saturday, 13th November 2021
Session 1: Peritoneal metastases of digestive origin
Chairs: Olivia Sgarbura, Martin Hubner, Sorin Alexandrescu
09:00-09:20 PM of gastric origin: the good, the bad, the ugly (Clarisse Eveno)
09:20-09:40 PM of colorectal origin: the good, the bad, the ugly (Olivia Sgarbura)
09:40-10:00 Integrative strategies for treating patients with PM of digestive origin (Thibault Mazard)
10:00-10:20 Optimizing peri-OP care to improve oncological outcomes (Martin Hübner)
10:20-10:40 Challenges for a successful PM program in Romania (Sorin Alexandrescu)
10:40-11:00 Incorporating Romania in the European chain for the treatment of PM (Adrian Bartos)
11:00-11:20 Break
Session 2: Colorectal cancer
Chairs: Marc Peeters, Adina Croitoru, Augustin Dima
11:20-11:40 How to treat patients with oligometastatic disease? (Augustin Dima)
11:40-12:00 Tumor regression grade (Vlad Herlea)
12:00-12:20 What biomarkers do we need to properly plan first line treatment and how to select the patients? (Marc Peeters)
12:20-12:40 Second and 3rd line treatment for metastatic CCR (Thomas Aparicio)
12:40-13:30 Lunch break
Session 3: Pancreatic cancer (1)
Chairs: Mariana Jinga, Mircea Manuc, Traian Dumitrascu
13:30-13:50 Endoscopic ultrasound in the diagnosis of pancreatic cancer (Mariana Jinga)
13:50-14:10 The role of the gastroenterologist in the management of pancreatic cancer (Gabriel Constantinescu?)
14:10-14:30 Detection and staging of pancreatic cancers (Mugur Grasu)
14:30-14:50 Surgery in pancreatic cancer (Traian Dumitrașcu)
14:50-15:10 Break
Session 4: Pancreatic cancer (2)
Chairs: Timon Vandamme, Tudor Ciuleanu, Dan Gheonea
15:10-15:30 Systemic therapy in metastatic pancreatic cancer (Iulia Gramaticu)
15:30-15:50 Neoadjuvant and adjuvant treatment in resectable pancreatic cancer (Timon Vandamme)
15:50-16:10 The role of MDT in the management of pancreatic cancer (Dan Gheonea?)
16:10-16:30 Top 5 recent publications in pancreatic cancer (Adina Croitoru)
16:30-16:50 What is next in pancreatic cancer? (Tudor Ciuleanu)
16:50-17:00 Closing remarks
The 10th Franco-Romanian Symposium on Digestive Oncology
Friday, 19th November 2021
08:50-09:00 Opening: Thomas Aparicio, Adina Croitoru, Mircea Diculescu, Mircea Mănuc
Session 1: Colon cancer (1)
Chairs: Sylvain Manfredi, Mircea Mănuc, Anca Mihailov
09:00-09:25 Developing screening programme in colorectal cancer (Mircea Mănuc)
09:25-09:50 Screening colorectal cancer, different European experiences (Sylvain Manfredi)
09:50-10:15 Minimally invasive surgery in colon cancer (Oana Stanciulea)
10:15-10:40 Liquid biopsy in our daily and future practice (Aziz Zaanan)
10:40-11:05 Adjuvant treatment for stage II and III colon cancer: For whom, how intensive, and how long? (Anca Mihailov)
11:05-11:25 Pharma symposium
11:25-11:40 Break
Session2: Colon cancer (2)
Chairs: Mirela Ionescu, Violaine Randrian, Mircea Diculescu
11:40-12:05 Understanding CRC biopsy: MSI, BRAF, RAS, immunoscore and others: which are the drivers of the malignancy and what do we have to understand? (Violaine Randrian)
12:05-12:30 Cancer and Inflammatory Bowel Diseases (Mircea Diculescu)
12:30-12:55 A glimpse into the future: Will preoperative treatment replace the standard sequence in early colon cancer? (Mehdi Karoui)
12:55-13:15 Lilly Symposium: Gastric cancer (Adina Croitoru)
13:15-14:15 Lunch break
Session 3: Rectal cancer (1)
Chairs: Cătălin Vasilescu, Adrian Săftoiu, Ioana Lupescu
14:15-14:40 Preoperative staging – how accurate is it? (Adrian Săftoiu)
14:40-15:05 Imaging of rectal cancer: What does the clinician have to know today – and will AI impact the future? (Ioana Lupescu)
15:05-15:30 Controversies in surgery in rectal cancer (Catalin Vasilescu)
15:30-15:55 Transrectal surgery in rectal cancer (Tudor Stefan)
15:55-16:20 Recurrence of treated rectal cancer (Antoine Brouquet)
16:20-16:45 Pharma symposium
16:45-17:00 Break
Session 4: Rectal cancer (2)
Chairs: Marc Pocard, _________________________________
17:00-17:25 Neoadjuvant chemotherapy plus CRT vs Preoperative CRT in locally advanced rectal cancer (Xenia Bacinski)
17:25-17:50 Functionnal results after multimodal treatment (Marc Pocard)
17:50-18:15 Updates from ESMO and ASCO in colorectal cancer (Thomas Aparicio)
Saturday, 20th November 2021
Session 5: Pancreatic cancer (1)
Chairs: Thomas Aparicio, Adina Croitoru, Mircea Manuc
09:00-09:25 (Cristian Gheorghe)
09:25-09:50 New strategies for the management of localised pancreatic cancer (Nicolas Williet)
09:50-10:15 (Răzvan Iacob)
10:15-10:40 The role of exosomes in pancreatic cancer (Irina Cazacu)
10:40-11:00 Pharma symposium
11:00-11:15 Break
Session 6: Pancreatic cancer (2)
Chairs: Laetitia Dahan, Adina Croitoru, Mircea Manuc
11:15-11:40 Surgery in pancreatic cancer (Lilian Schwarz)
11:40-12:05 Radiotherapy in pancreatic cancer (Cristina Iftode)
12:05-12:30 Sequencing treatments in pancreatic cancer (Laetitia Dahan)
12:30-12:55 Updates from ESMO and ASCO in pancreatic cancer (Anna Pellat)
12:55-13:15 Pharma symposium
13:15-14:30 Closing remarks